Dan W. Denney

2.3k total citations · 1 hit paper
14 papers, 1.7k citations indexed

About

Dan W. Denney is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dan W. Denney has authored 14 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dan W. Denney's work include Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (4 papers). Dan W. Denney is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and T-cell and B-cell Immunology (4 papers). Dan W. Denney collaborates with scholars based in United States, Canada and South Sudan. Dan W. Denney's co-authors include Ann Marie Stanley, Kasra X. Ramyar, Daniel J. Leahy, Sandra B. Gabelli, Hyun‐Soo Cho, J I Bell, John A. Todd, H O McDevitt, Karen Mason and Harden M. McConnell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Dan W. Denney

14 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

2003 1.2k citations Hyun‐Soo Cho, Kasra X. Ramyar et al. Nature profile →

Peers

Countries citing papers authored by Dan W. Denney

Since Specialization

Citations

This map shows the geographic impact of Dan W. Denney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan W. Denney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan W. Denney more than expected).

Fields of papers citing papers by Dan W. Denney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan W. Denney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan W. Denney. The network helps show where Dan W. Denney may publish in the future.

Co-authorship network of co-authors of Dan W. Denney

This figure shows the co-authorship network connecting the top 25 collaborators of Dan W. Denney. A scholar is included among the top collaborators of Dan W. Denney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan W. Denney. Dan W. Denney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma 2009 ·Leukemia & lymphoma ·John M. Timmerman, Julie M. Vose, Debra K. Czerwinski, Wen-Kai Weng, Diane E. Ingolia, (unknown), Dan W. Denney, Ronald Levy	28
2	Abstract LB-204: Results of a Phase 3 trial evaluating safety and efficacy of specific immunotherapy, recombinant idiotype (Id) conjugated to KLH (Id-KLH) with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymph 2008 ·Cancer Research ·Ronald Levy, M. J. Robertson, Kristen N. Ganjoo, John E. Leonard, (unknown), Dan W. Denney	45
3	Preliminary immune response (IR) results of a phase 2 study with idiotype (Id) immunotherapy after treatment with CVP and rituximab for follicular non-Hodgkin’s lymphoma (FL) 2006 ·Journal of Clinical Oncology ·John P. Leonard, Kathryn A. Mason, (unknown), (unknown), Thierry Sornasse, Diane E. Ingolia, (unknown), Dan W. Denney	4
4	Long-Term Follow-Up of Patients Treated in a Phase 2 Trial with MyVax® Personalized Immunotherapy (Recombinant Id-KLH with GM-CSF) after Chemotherapy as Initial Treatment for Follicular Non-Hodgkin’s Lymphoma (NHL). 2005 ·Blood ·John M. Timmerman, Julie M. Vose, Ronald Levy, (unknown), Dan W. Denney	5
5	Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab breakdown → 2003 ·Nature ·Hyun‐Soo Cho, (unknown), Kasra X. Ramyar, Ann Marie Stanley, Sandra B. Gabelli, Dan W. Denney, Daniel J. Leahy	1206
6	T cell antigen receptor vaccines for active immunotherapy of T cell malignancies 1998 ·The FASEB Journal ·Carmen P. Wong, Craig Okada, John M. Timmerman, Dan W. Denney, Ronald Levy	1
7	Mouse class II transactivator: cDNA sequence and amino acid comparison with the human class II transactivator 1997 ·Immunogenetics ·Tasha N. Sims, John F. Elliott, Vido Ramassar, Dan W. Denney, Philip F. Halloran	18
8	TCR vaccines for active immunotherapy of T cell malignancies 1997 ·The Journal of Immunology ·Craig Okada, Carmen P. Wong, Dan W. Denney, Ronald Levy	37
9	Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH. 1995 ·The Journal of Immunology ·Karen Mason, Dan W. Denney, Harden M. McConnell	56
10	Kinetics of the Reaction of a Myelin Basic Protein Peptide with Soluble IAu 1995 ·Biochemistry ·Karen Mason, Dan W. Denney, Harden M. McConnell	19
11	Molecular mapping of class II polymorphisms in the human major histocompatibility complex. I. DR beta. 1987 ·The Journal of Immunology ·J I Bell, Dan W. Denney, Armand J. MacMurray, (unknown), Diane Watling, H O McDevitt	47
12	Allelic variation in the DR subregion of the human major histocompatibility complex. 1987 ·Proceedings of the National Academy of Sciences ·J I Bell, Dan W. Denney, (unknown), (unknown), John A. Todd, H O McDevitt	193
13	Multiple genetic mechanisms have contributed to the generation of the HLA-A2/A28 family of class I MHC molecules. 1987 ·The Journal of Immunology ·Niall Holmes, P D Ennis, (unknown), Dan W. Denney, Peter Parham	65
14	Molecular Biology of the Class II Region of the Human Major Histocompatibility Complex 1986 ·Cold Spring Harbor Symposia on Quantitative Biology ·(unknown), Dan W. Denney, (unknown), (unknown), D. A. Hardy, H O McDevitt	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact